Comparing 19 vendors in Peptide Synthesis startups across 0 criteria.
Peptide synthesis refers to producing peptides short chains of amino acids—using either chemical or biological methodologies. Chemical synthesis, including Solid-Phase and Liquid-Phase techniques, enables precise, scalable assembly of peptides through controlled reactions. Biological synthesis leverages advanced biotechnological tools, such as recombinant DNA technology and enzymatic systems, to produce peptides in living cells or in vitro.
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered and Regional Scope
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Unit Considered
1.6 Limitations
1.7 Stakeholders
2.1 Introduction
2.2 Market Dynamics
2.2.1 Drivers
2.2.1.1 Advancements in peptide therapeutics
2.2.1.2 Innovations in peptide synthesis instruments
2.2.1.3 Growing use of peptides in diagnostics and research
2.2.2 Restraints
2.2.2.1 Regulatory hurdles
2.2.2.2 High cost of peptide synthesis and instruments
2.2.3 Opportunities
2.2.3.1 Adoption of personalized medicine
2.2.3.2 Strategic collaborations and partnerships
2.2.4 Challenges
2.2.4.1 Immunogenicity issues
2.2.4.2 Environmental concerns
2.3 Trends/Disruptions Impacting Customer Business
2.4 Value Chain Analysis
2.5 Ecosystem Analysis
2.6 Investment and Funding Scenario
2.7 Technology Analysis
2.7.1 Key Technologies
2.7.2 Complementary Technologies
2.7.3 Adjacent Technologies
2.8 Patent Analysis
2.9 Trade Analysis
2.10 Porter’s Five Forces Analysis
2.10.1 Threat of New Entrants
2.10.2 Threat of Substitutes
2.10.3 Bargaining Power of Suppliers
2.10.4 Bargaining Power of Buyers
2.10.5 Intensity of Competitive Rivalry
3.1 Introduction
3.2 Key Player Strategies/Right to Win
3.3 Revenue Analysis
3.4 Market Share Analysis
3.5 Company Valuation and Financial Metrics
3.6 Brand/Product Comparison
3.7 Company Evaluation Matrix: Startups/SMEs
3.7.1 Progressive Companies
3.7.2 Responsive Companies
3.7.3 Dynamic Companies
3.7.4 Starting Blocks
3.7.5 Competitive Benchmarking: Startups/SMEs
3.7.5.1 Detailed list of key startups/SMEs
3.7.5.2 Competitive benchmarking of key startups/SMEs
3.8 Competitive Scenario
3.8.1 Product Launches
3.8.2 Deals
3.8.3 Expansions
4.1 AAPPTec
4.1.1 Business overview
4.1.2 Products/Solutions/Services offered
4.1.3 Recent developments
4.2 Abyntek
4.2.1 Business overview
4.2.2 Products/Solutions/Services offered
4.2.3 Recent developments
4.3 Activotec
4.3.1 Business overview
4.3.2 Products/Solutions/Services offered
4.3.3 Recent developments
4.4 AmbioPharm Inc.
4.4.1 Business overview
4.4.2 Products/Solutions/Services offered
4.4.3 Recent developments
4.5 Amide
4.5.1 Business overview
4.5.2 Products/Solutions/Services offered
4.5.3 Recent developments
4.6 AnyGen
4.6.1 Business overview
4.6.2 Products/Solutions/Services offered
4.6.3 Recent developments
4.7 Aurigene Pharmaceutical Services Ltd.
4.7.1 Business overview
4.7.2 Products/Solutions/Services offered
4.7.3 Recent developments
4.8 Biomatik
4.8.1 Business overview
4.8.2 Products/Solutions/Services offered
4.8.3 Recent developments
4.9 CPC Scientific Inc.
4.9.1 Business overview
4.9.2 Products/Solutions/Services offered
4.9.3 Recent developments
4.10 CUSABIO
4.10.1 Business overview
4.10.2 Products/Solutions/Services offered
4.10.3 Recent developments
4.11 ChemPep
4.11.1 Business overview
4.11.2 Products/Solutions/Services offered
4.11.3 Recent developments
4.12 Proteogenix
4.12.1 Business overview
4.12.2 Products/Solutions/Services offered
4.12.3 Recent developments
4.13 CordenPharma
4.13.1 Business overview
4.13.2 Products/Solutions/Services offered
4.13.3 Recent developments
4.14 IRIS BIOTECH GMBH
4.14.1 Business overview
4.14.2 Products/Solutions/Services offered
4.14.3 Recent developments
4.15 JPT Peptide Technologies GmbH
4.15.1 Business overview
4.15.2 Products/Solutions/Services offered
4.15.3 Recent developments
4.16 Luxembourg Bio Technologies
4.16.1 Business overview
4.16.2 Products/Solutions/Services offered
4.16.3 Recent developments
4.17 PeptiSystems
4.17.1 Business overview
4.17.2 Products/Solutions/Services offered
4.17.3 Recent developments
4.18 Peptide 2.0 Incorporated
4.18.1 Business overview
4.18.2 Products/Solutions/Services offered
4.18.3 Recent developments
4.19 SB-PEPTIDE
4.19.1 Business overview
4.19.2 Products/Solutions/Services offered
4.19.3 Recent developments
Company Profiles
Strategy, financials, growth, and SWOT
Market Insights
Visual quadrant of competitors and leaders
Benchmarking
Compare by product, region, and end-user
Lead Gen Add-on
Use the quadrant to attract clients
WuXi AppTec
Jul 2025
Medical Product Outsourcing
Jul 2025
WuXi AppTec
Jul 2025
Vietnam Investment Review - VIR
Jun 2025
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
Email : [email protected]
Quick Links
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
Company
Headquarters
Year Founded
Holding Type